Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: A further contribution

Journal of Pediatric Endocrinology and Metabolism

Volumn 16, Issue 7, 2003, Pages 1005-1010

  Pucarelli, Ida ^a   Segni, Maria ^a   Ortore, Massimiliano ^a   Arcadi, Elena ^a   Pasquino, Anna Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Central precocious puberty; GnRH analogues; Growth hormone; Growth velocity

Indexed keywords

FOLLITROPIN; GONADORELIN AGONIST; LUTEINIZING HORMONE; RECOMBINANT GROWTH HORMONE;

ARTICLE; BODY BUILD; BODY HEIGHT; BONE AGE; BONE MATURATION; CHILD; CLINICAL ARTICLE; CLINICAL RESEARCH; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HUMAN; PRECOCIOUS PUBERTY;

EID: 0141891455     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2003.16.7.1005     Document Type: Article

References (38)

1. Kaplan SL, Grumbach MM. Clinical review: Pathophysiology and treatment of sexual precocity. J Clin Endocrinol Metab 1990; 71: 785-789.
2. Kletter GB, Kelch RP. Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 1994; 79: 331-334.
3. Rosenfield RL. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr 1994; 124: 989-991.
4. Conn PM, Crowley WFJ. Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994; 45: 391-405.
5. Kappy MS, Ganong CS. Advances in the treatment of precocious puberty. Adv Pediatr 1994; 41: 223-261.
6. Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler GB. Adult height in precocious puberty after long-term treatment with deslorelin. J Clin Endocrinol Metab 1991; 73: 1235-1240.
7. Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Corrias A, De Luca F, De Sanctis C, Rigon F, Zamboni G, Bernasconi S, Chiumello G, Severi F, Tatò L. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. Acta Paediatr 1994; 83: 1052-1056.
8. Brauner R, Adan L, Malandry F, Zantleifer D. Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab 1994; 79: 415-420.
9. Cacciari E, Cassio A, Balsamo A, Colli C, Cicognani A, Pirazzoli P, Tani G, Brondelli L, Mandini M, Bovicelli L. Long-term follow-up and final height in girls with central precocious puberty treated with luteinizing hormone-releasing hormone analogue nasal spray. Arch Pediatr Adolesc Med 1994; 148: 1194-1199.
10. Stasiowska B, Vannelli S, Benso L. Final height in sexually precocious girls after therapy with an intranasal analogue of gonadotrophin-releasing hormone (Buserelin). Horm Res 1994; 42: 81-85.
11. Paul D, Conte FA, Grumbach MM, Kaplan SL. Long term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab 1995; 80: 546-551.
12. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C, Jansen M, Gerver WJ, Waelkens J, Drop S. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 1996; 75: 292-297.
13. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. Horm Res 1997; 47: 54-61.
14. Bertelloni S, Baroncelli GI, Sorentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998; 157: 363-367.
15. Galluzzi F, Salti R, Bindi G, Pasquini E, La Cauza C. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy. Acta Paediatr 1998; 87: 521-527.
16. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 1999; 141: 140-144.
17. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 1999; 84: 1973-1978.
18. Heger S, Partsch C-J, Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999; 84: 4583-4590.
19. Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, Delemarre-van de Waal HA, Waelkens JJJ, Drop SLS. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab 2000; 13: 765-772.
20. Klein KO, Barnes KM, Jones JV, Feuillan P, Cutler GB. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experiences. J Clin Endocrinol Metab 2001; 86: 4711-4716.
21. Oostdijik W, Drop SLS, Odink RJH, Hummelink R, Partsch CJ, Sipell WG. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Acta Paediatr Scand 1991; Suppl 372: 39-45.
22. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G, Battini R. Growth velocity and serum aminoterminal propeptide of type III procollagen in precocious puberty during gonadotropin-releasing hormone analogue treatment. Acta Paediatr 1993; 82: 261-266.
23. Stanhope R, Pringle PJ, Brook CGD. Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue. Acta Paediatr Scand 1988; 77: 525-530.
24. Di Martino-Nardi J, Wu R, Fishman K, Saenger P. The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty. J Clin Endocrinol Metab 1991; 73: 902-906.
25. Di Martino-Nardi J, Wu R, Varner R, Wong WLT, Saenger P. The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein. J Clin Endocrinol Metab 1994; 78: 664-668.
26. Sklar CA, Rothenberg S, Blumberg D, Oberfield SE, Levine LS, David R. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion. J Clin Endocrinol Metab 1991; 73: 734-738.
27. Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC, Cutler GB. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty. J Clin Endocrinol Metab 1991; 72: 301-307.
28. Saggese G, Pasquino AM, Bertelloni S, Baroncelli GI, Battini R, Pucarelli I, Segni M, Franchi G. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr 1995; 84: 299-304.
29. Tatò L, Saggese G, Cavallo L, Antoniazzi F, Corrias A, Pasquino AM, Cisternino M. Use of combined GnRH-agonist and hGH therapy for better attaining the goals in precocious puberty treatment. Horm Res 1995; 44 (Suppl 3): 49-54.
30. Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone. J Clin Endocrinol Metab 1999; 84: 449-452.
31. Kohn B, Julius JR, Blethen SL. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the National Cooperative Growth Study experience. Pediatrics 1999; 104: 1014-1017.
32. Walvoord EC, Pescovitz OH. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics 1999; 104: 1010-1014.
33. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
34. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd Ed. Stanford, CA: Stanford University Press, 1959.
35. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich and Pyle hand standards. J Pediatr 1952; 40: 423-441.
36. Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 allowing for height of parents. Arch Dis Child 1970; 45: 755-762.
37. Caro JF. Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 1991; 73: 691-695.
38. Bridges NA, Cooke A, Healy MJR, Hindmarsh PC, Brook CGD. Ovaries in sexual precocity. Clin Endocrinol 1995; 42: 135-140.